Preventive Care and Immunizations

105 questions

Question 21Question →

A mother brings her 15-month-old son to the pediatric office for a scheduled health maintenance visit. She expresses concern regarding his speech, noting he only uses four distinct words regularly. Observations in the clinic show the child walking independently, stacking three blocks, and pointing to objects he desires. He follows a simple command to 'give me the ball'. His temperature is 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}) and physical examination is entirely normal. He had a mild viral rhinitis one week ago, but his symptoms have fully resolved. The mother asks about the appropriateness of giving him his scheduled immunizations today given his recent cold and speech development. Which of the following is the most appropriate action?

Show answer & explanation

Answer: Reassure the mother that his development is on track and administer all scheduled vaccines today

Answer

Reassure the mother that his development is on track and administer all scheduled vaccines today
The patient's development is entirely age-appropriate for a 15-month-old. Normal milestones at this age include walking independently (gross motor), stacking two to three blocks (fine motor), knowing three to five words (language), and pointing to objects to share interest (social/cognitive). Because his development is normal, reassurance is indicated. Furthermore, a mild, recently resolved illness without high fever is not a contraindication to any scheduled immunizations, including live-attenuated vaccines. Therefore, all scheduled vaccines should be administered.

Step-by-Step Solution

1
Evaluate the child's developmental milestones for his age (15 months).
The child can walk independently (gross motor), stack three blocks (fine motor), use four distinct words (language), and point to objects (social/cognitive). All of these milestones are normal for a 15-month-old.
To determine if developmental referrals or further testing are necessary based on the mother's concerns.
2
Assess the patient's immunization status and evaluate whether his recent mild illness is a contraindication.
A recently resolved mild viral rhinitis without significant fever is not a contraindication to any vaccines, including live-attenuated ones.
To ensure standard preventive care is safely provided without unnecessary delays.

Key Concept

Normal developmental milestones at 15 months and standard immunization contraindications.
Estimated Time:1m 0s
Question 22Question →

A 12-month-old boy is brought to the clinic for a routine well-child evaluation. His mother, who is 18 weeks pregnant, reports that he is doing well but expresses concern that he is not yet walking independently. On evaluation, the infant is able to pull himself to a stand, cruises along the examination table, and uses a neat pincer grasp to pick up small objects. He babbles frequently, says "mama" and "dada" specifically to his parents, and plays peek-a-boo. The infant is up to date on all immunizations administered prior to 12 months of age. His mother asks if his required immunizations for today are safe for her unborn baby. Which of the following is the most appropriate management for this patient?

Show answer & explanation

Answer: Administer all indicated age-appropriate vaccines and provide routine developmental anticipatory guidance

Answer

Administer all indicated age-appropriate vaccines and provide routine developmental anticipatory guidance
At the 12-month well-child visit, children are scheduled to receive several vaccines, including their first doses of live-attenuated vaccines, namely the measles, mumps, and rubella (MMR) vaccine and the varicella vaccine. A common concern for parents is the safety of these vaccines when there is a pregnant woman in the household. According to guidelines, the presence of a pregnant household contact is not a contraindication to the administration of MMR or varicella vaccines to a healthy child. The MMR vaccine virus is not transmitted to close contacts. The varicella vaccine virus can theoretically be transmitted if the immunized child develops a post-vaccination vesicular rash, but this is exceptionally rare. Routine isolation is unnecessary unless a rash develops. Furthermore, the child's developmental milestones—cruising, using a neat pincer grasp, and saying 'mama' and 'dada' specifically—are perfectly appropriate for a 12-month-old, meaning routine anticipatory guidance is all that is required for developmental management.

Step-by-Step Solution

1
Evaluate the child's developmental milestones based on his chronological age of 12 months.
Pulling to stand, cruising, displaying a neat pincer grasp, and saying specific words like "mama" and "dada" are entirely normal findings for a 12-month-old.
To determine whether early intervention or specialized referral is indicated for a developmental delay.
2
Identify the routine immunizations due at the 12-month well-child visit.
The standard schedule includes the first doses of live-attenuated vaccines (MMR, varicella) alongside inactivated vaccines (e.g., PCV, Hib, HepA).
To ensure the child receives comprehensive preventive care according to established guidelines.
3
Assess for potential contraindications to live-attenuated vaccines based on the mother's pregnancy.
Pregnancy in a household contact is not a contraindication for a child to receive MMR or varicella vaccines, and no special isolation precautions are necessary.
To adhere to public health guidelines that protect both the vaccinated child and pregnant household contacts through herd immunity.

Key Concept

Live-attenuated vaccines (such as MMR and varicella) are completely safe and routinely indicated for immunocompetent children who have pregnant household contacts. Additionally, pulling to stand and cruising are normal gross motor milestones for a 12-month-old; independent walking is not strictly expected until 15 to 18 months of age.
Question 23Question →

A medical student is reviewing normal gross motor developmental milestones in preparation for performing routine well-child screening examinations. Arrange the following gross motor milestones in the chronological order they typically appear in a healthy infant.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence of gross motor development is: rolling from prone to supine, sitting momentarily without support, pulling to stand, and finally walking independently.
Gross motor development progresses in a predictable cephalocaudal (head-to-toe) direction. An infant typically learns to roll from prone to supine at 4 months, sits unsupported at 6 months, pulls to a standing position at 9 months, and walks independently by 12 to 15 months.

Step-by-Step Solution

1
Determine the typical age for rolling from prone to supine.
Typically occurs at 4 months of age.
This early milestone requires head and upper trunk control.
2
Determine the typical age for sitting without support.
Typically occurs at 6 months of age.
This requires further development of core truncal stability.
3
Determine the typical age for pulling to stand.
Typically occurs at 9 months of age.
This requires lower extremity strength and coordination.
4
Determine the typical age for walking independently.
Typically occurs at 12 to 15 months of age.
This is the culmination of infant gross motor development requiring full balance and coordination.
5
Arrange the milestones sequentially by age.
The order is 4 months, 6 months, 9 months, and 12-15 months.
Developmental milestones follow a predictable chronological and cephalocaudal progression.

Key Concept

Normal sequence of gross motor development in the first year of life
Estimated Time:45s
Question 24Question →

Match each pediatric patient scenario with the most appropriate specific preventive care or immunization recommendation.

Click a left item, then click its matching right item

Items

A 4-year-old boy with sickle cell anemia who is otherwise healthy.
A 15-month-old girl receiving daily tacrolimus following a liver transplant.
A 6-month-old boy born prematurely at 28 weeks gestation with no chronic medical conditions.
A 12-year-old girl recently diagnosed with a terminal complement component (C5-C9) deficiency.

Matches

Show answer & explanation

Answer

Sickle cell anemia pairs with daily prophylactic penicillin V. Liver transplant on tacrolimus pairs with contraindication to live-attenuated vaccines. The preterm infant pairs with routine childhood immunizations according to chronological age. Terminal complement deficiency pairs with both MenACWY and MenB vaccines.
Each listed high-risk pediatric condition demands tailored preventive care. Sickle cell disease causes early functional asplenia, heavily relying on penicillin prophylaxis. Immunosuppression for solid organ transplants creates profound cellular immunodeficiency, strongly contraindicating live vaccines. Prematurity requires standard, prompt vaccination by chronological age to close vulnerability windows. Finally, terminal complement deficiency uniquely impairs the membrane attack complex, necessitating broad and aggressive meningococcal vaccination coverage.

Step-by-Step Solution

1
Analyze the preventive needs for the patient with sickle cell disease.
Identified a severe risk of functional asplenia.
Functional asplenia requires rigorous pneumococcal vaccination and prophylactic penicillin V until 5 years of age.
2
Evaluate the immune status of the liver transplant recipient.
Identified severe iatrogenic immunosuppression.
Maintenance immunosuppressive medications like tacrolimus strictly contraindicate the administration of live-attenuated vaccines.
3
Determine the optimal vaccination protocol for the premature infant.
Identified standard chronological age scheduling.
Premature infants should not be subjected to delayed schedules; they must receive vaccines based strictly on their chronological age.
4
Identify the primary infectious risk associated with a terminal complement deficiency.
Identified an isolated, profound susceptibility to encapsulated organisms, particularly Neisseria meningitidis.
The inability to form the membrane attack complex explicitly requires targeted and comprehensive meningococcal vaccination (MenACWY and MenB).

Key Concept

Tailored immunization and preventive care protocols for high-risk pediatric populations (functional asplenia, severe immunosuppression, prematurity, and specific immunodeficiencies).
Question 25Question →

A 2-month-old boy is brought to the clinic for a routine well-child visit. He was diagnosed with 22q11.2 deletion syndrome shortly after birth following an evaluation for a cardiac murmur and tetany. Echocardiography at that time revealed a tetralogy of Fallot, which is awaiting surgical repair. Recent immunologic evaluation demonstrated a markedly reduced CD3+ T-lymphocyte count of 200/mm³. Today, the infant is feeding well and gaining weight appropriately. During the examination, he demonstrates a social smile, vocalizes with cooing sounds, and tracks a colorful toy past the midline. He does not yet roll over or reach for objects. The mother expresses concern that his development may be delayed. His immunization records show he received the hepatitis B vaccine at birth and 1 month of age. Which of the following is the most appropriate management for this patient today?

Show answer & explanation

Answer: Reassure the mother regarding his development; administer DTaP, Hib, IPV, and PCV vaccines; and defer the rotavirus vaccine

Answer

Reassure the mother regarding his development; administer DTaP, Hib, IPV, and PCV vaccines; and defer the rotavirus vaccine.
The correct answer addresses both the patient's normal development and the necessary modifications to his immunization schedule. A 2-month-old infant is expected to demonstrate a social smile, coo, and track objects past the midline. The inability to roll over or reach for objects is normal at this age (these are typically achieved by 4 months). Therefore, the mother should be reassured. Regarding immunizations, this patient has 22q11.2 deletion syndrome (DiGeorge syndrome) with confirmed severe T-lymphocyte deficiency. Live-attenuated vaccines, such as the oral rotavirus vaccine, are absolutely contraindicated in patients with severe cell-mediated immunodeficiencies due to the risk of uncontrolled vaccine-strain infection. However, inactivated, toxoid, and subunit vaccines (DTaP, Hib, IPV, PCV) are safe and should be administered according to the routine schedule to provide necessary protection.

Step-by-Step Solution

1
Evaluate the infant's developmental milestones based on his chronological age of 2 months.
The infant exhibits a social smile, cooing, and tracking past the midline, which are normal 2-month milestones. Rolling over and reaching for objects are typically achieved at 4 months.
Accurate milestone assessment prevents unnecessary anxiety and improper referrals for early intervention.
2
Identify the implications of the patient's underlying genetic diagnosis.
22q11.2 deletion syndrome (DiGeorge syndrome) is associated with thymic hypoplasia, leading to severe T-lymphocyte deficiency, confirmed here by a low CD3+ count.
Understanding the patient's immune status is critical for safely prescribing immunizations.
3
Determine the contraindications for the standard 2-month immunization bundle.
The standard 2-month bundle includes DTaP, Hib, IPV, PCV, and rotavirus. Rotavirus is a live-attenuated vaccine and is absolutely contraindicated in severe cell-mediated immunodeficiencies.
Live-attenuated vaccines can cause severe, disseminated disease in patients with profound T-cell defects.
4
Formulate the final management plan.
Reassure the mother that development is normal, safely administer the inactivated vaccines (DTaP, Hib, IPV, PCV), and withhold the rotavirus vaccine.
Inactivated vaccines are safe and essential for protecting immunocompromised patients from invasive bacterial and viral infections.

Key Concept

Live-attenuated vaccines (e.g., rotavirus) are contraindicated in patients with severe cell-mediated immunodeficiencies (e.g., severe DiGeorge syndrome), whereas inactivated vaccines should be administered on schedule. Normal 2-month milestones include social smiling, cooing, and tracking past the midline.
Question 26Question →

A 4-month-old girl is brought to the pediatrician for a routine well-child visit. She was born at 32 weeks gestation and had an uncomplicated neonatal intensive care unit stay before being discharged at 36 weeks postmenstrual age. For the past two days, she has had clear rhinorrhea and a mild cough. Her temperature is 37.6°C (99.7°F), pulse is 120/min, and respirations are 32/min. Physical examination reveals clear lung fields and no increased work of breathing. The father expresses concern about administering vaccines today because the infant is "fighting off a cold" and because she was born prematurely. She received her 2-month immunizations without any adverse events. Which of the following is the most appropriate recommendation regarding her immunizations today?

Show answer & explanation

Answer: Administer all scheduled 4-month vaccines today

Answer

Administer all scheduled 4-month vaccines today
The correct approach is to administer all scheduled 4-month vaccines today. This patient presents with two common 'false contraindications' to vaccination: a history of prematurity and a concurrent mild acute illness. According to guidelines from the American Academy of Pediatrics (AAP) and the Centers for Disease Control and Prevention (CDC), prematurely born infants should be immunized according to their chronological age, not their corrected gestational age. Their immune systems are capable of mounting an adequate response, and they are often at higher risk for complications from vaccine-preventable diseases. Furthermore, a mild acute illness (such as a viral upper respiratory infection), with or without a low-grade fever, is not a contraindication to receiving any vaccines. Delaying vaccines in these scenarios leads to missed opportunities for immunization and leaves the infant vulnerable to serious infections.

Step-by-Step Solution

1
Evaluate the infant's clinical presentation for true vaccine contraindications.
The infant has clear rhinorrhea, a mild cough, and a low-grade temperature of 37.6°C (99.7°F).
Mild acute illnesses are common and do not decrease vaccine efficacy or increase the risk of adverse events.
2
Assess the impact of the patient's prematurity on the immunization schedule.
The infant was born at 32 weeks gestation and is currently 4 months chronological age.
Premature infants should receive immunizations based on their chronological age, not corrected age, to ensure timely protection.
3
Determine the most appropriate management plan based on current guidelines.
Proceed with administering the standard 4-month immunizations (DTaP, PCV, Hib, IPV, and Rotavirus).
Neither the mild upper respiratory infection nor the history of prematurity are contraindications to routine vaccination.

Key Concept

Routine childhood immunizations should be administered based on chronological age in premature infants, and mild acute illnesses are false contraindications to vaccination.
Question 27Question →

A 12-month-old boy is brought to the pediatrician for a routine well-child visit. His medical history is significant for perinatal HIV infection. He is currently prescribed antiretroviral therapy, but his mother admits to frequently missing doses over the past few months. Recent laboratory studies show a CD4 T-lymphocyte count of 450 cells/mm³ and a CD4 percentage of 12%. The parents express concern about his physical development, noting that he is not yet able to run or kick a ball. On examination, the boy is alert and interactive. He can stand independently for a few seconds and uses a fine pincer grasp to pick up a raisin. He says "mama" and "dada" specifically and waves "bye-bye" to the clinician. He has received all previously recommended immunizations. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Administer age-appropriate inactivated vaccines only and reassure the parents regarding his development

Answer

The most appropriate next step is to administer age-appropriate inactivated vaccines only and reassure the parents regarding his development.
The correct action is to provide inactivated vaccines only and offer reassurance regarding development. Routine 12-month immunizations typically include inactivated vaccines (such as PCV, Hib, HepA) and live-attenuated vaccines (MMR, Varicella). However, for pediatric patients with perinatal HIV, the administration of live vaccines depends on their immune status. A CD4 percentage < 15% indicates severe immunosuppression, making live vaccines strictly contraindicated. Inactivated vaccines are safe and must be administered to protect this vulnerable patient. Regarding his development, standing alone, having a fine pincer grasp, saying specific words ("mama/dada"), and waving bye-bye are normal 12-month milestones. Running and kicking a ball are not expected until 18 to 24 months. Therefore, the parents should be reassured without needing a developmental referral.

Step-by-Step Solution

1
Evaluate the patient's immune status and determine vaccine eligibility.
The patient has HIV with a CD4 percentage of 12%, which defines severe immunosuppression in a child under 5 years old.
Live-attenuated vaccines (e.g., MMR, Varicella) are contraindicated in severely immunocompromised patients (CD4 < 15%) due to the risk of life-threatening vaccine-strain infection.
2
Identify the appropriate vaccines to administer at this 12-month visit.
The patient should receive scheduled inactivated vaccines (e.g., PCV, Hib, HepA) but not the normally scheduled 12-month live vaccines (MMR, Varicella).
Inactivated vaccines pose no risk of disseminated infection and should be given on schedule to protect the vulnerable host.
3
Assess the patient's developmental milestones against parental expectations.
The patient can stand independently, use a fine pincer grasp, say specific words, and wave bye-bye. These are appropriate 12-month milestones.
The parents expect 18- to 24-month milestones (running, kicking a ball). Reassurance is needed, not a developmental referral, as the child is developing normally for his age.

Key Concept

In pediatric patients with HIV, live-attenuated vaccines are contraindicated if there is severe immunosuppression (CD4 percentage < 15%). Normal 12-month milestones include standing independently, a fine pincer grasp, and saying 1-3 specific words.
Question 28Question →

During routine well-child care, clinicians follow standardized periodicity schedules to ensure appropriate preventive screening for asymptomatic children and adolescents. Arrange the following universal preventive screening assessments in chronological order, starting with the earliest recommended age of initial administration to the latest.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for the initial administration of these universal screenings is: Autism spectrum disorder (18 months), Dyslipidemia (9-11 years), Major depressive disorder (12 years), and HIV infection (15-18 years).
Preventive care guidelines emphasize specific universal screening milestones. Autism screening is performed in early toddlerhood (18 and 24 months). Dyslipidemia screening is universally performed in late childhood (9-11 years) before pubertal lipid shifts. Depression screening is initiated in early adolescence (12 years) and performed annually thereafter. Finally, a one-time universal HIV screen is recommended in mid-to-late adolescence (15-18 years).

Step-by-Step Solution

1
Determine the initial age for universal autism spectrum disorder (ASD) screening.
ASD screening is universally conducted at 18 and 24 months.
Early identification and intervention for neurodevelopmental delays significantly improve long-term outcomes.
2
Determine the initial age for universal dyslipidemia screening.
Lipid screening is universally conducted once between 9 and 11 years of age.
Targeted screening misses a significant portion of children with familial hypercholesterolemia. Screening is done before puberty because normal pubertal changes can falsely lower HDL and raise triglycerides.
3
Determine the initial age for universal depression screening.
Depression screening begins at age 12 years.
The incidence of major depressive disorder rises sharply during adolescence, making annual screening critical starting at this age.
4
Determine the age for universal HIV screening.
HIV screening is conducted at least once between 15 and 18 years of age.
This captures the population as they enter peak years of sexual debut, recognizing that relying solely on risk-based screening misses many infected youth.

Key Concept

Chronological timeline of routine universal pediatric and adolescent preventive screenings
Question 29Question →

A medical student is reviewing the routine childhood immunization schedule recommended by the Centers for Disease Control and Prevention (CDC). Arrange the following vaccines in chronological order based on the recommended age for the administration of the FIRST dose in a healthy, full-term infant.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence for the first doses of these vaccines is: Hepatitis B (birth), DTaP (2 months), MMR (12 months), and HPV (11-12 years).
The standard CDC immunization schedule dictates that the first dose of the Hepatitis B vaccine is given at birth. The primary series for the DTaP vaccine begins at 2 months of age. The MMR vaccine is delayed until 12 months of age because it is a live-attenuated vaccine and requires the clearance of maternal antibodies for optimal efficacy. Finally, the HPV vaccine is administered starting at 11-12 years of age. This sequence correctly reflects the chronological administration of these vaccines in a healthy child.

Step-by-Step Solution

1
Identify the recommended age for the first dose of the Hepatitis B vaccine.
Birth.
Hepatitis B is the only routine vaccine given to healthy newborns before hospital discharge to prevent perinatal transmission.
2
Identify the recommended age for the first dose of the DTaP vaccine.
2 months.
The primary infant series for DTaP, along with IPV, Hib, PCV, and Rotavirus, begins at 2 months of age.
3
Identify the recommended age for the first dose of the MMR vaccine.
12 to 15 months.
Live-attenuated vaccines like MMR and Varicella are generally withheld until at least 12 months of age to prevent interference from maternal antibodies.
4
Identify the recommended age for the first dose of the HPV vaccine.
11 to 12 years.
The HPV vaccine is targeted for early adolescence, before the expected onset of sexual activity.

Key Concept

Routine Childhood Immunization Schedule Timing
Question 30Question →

A 15-month-old girl is brought to the clinic for a routine well-child visit. She underwent a liver transplant four months ago due to biliary atresia and is currently maintained on an immunosuppressive regimen of tacrolimus and mycophenolate mofetil. The patient is doing well, and her physical examination is unremarkable. According to her immunization record, she received all recommended vaccines up to 6 months of age, but has not received any vaccines since her transplant. The parents inquire about updating her immunizations. Which of the following is the most appropriate action regarding her immunizations today?

Show answer & explanation

Answer: Administer the pneumococcal conjugate vaccine and withhold the measles, mumps, and rubella (MMR) vaccine.

Answer

Administer the pneumococcal conjugate vaccine and withhold the measles, mumps, and rubella (MMR) vaccine.
This patient is severely immunocompromised due to her post-transplant medication regimen. In such patients, inactivated vaccines like the pneumococcal conjugate vaccine are safe and highly recommended to prevent serious infections. However, live-attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, are strictly contraindicated because the weakened viruses can multiply unchecked and cause severe, disseminated disease.

Step-by-Step Solution

1
Evaluate the patient's immune status based on the clinical history.
The patient is on tacrolimus and mycophenolate mofetil following a liver transplant, making her severely immunocompromised.
A patient's immune status dictates the safety and scheduling of different vaccine types.
2
Determine the safety of the indicated catch-up vaccines.
Live-attenuated vaccines (like MMR and varicella) are strictly contraindicated. Inactivated vaccines (like pneumococcal conjugate and DTaP) are safe and recommended.
Live-attenuated vaccines can cause life-threatening infections in hosts lacking sufficient cellular immunity.
3
Select the correct immunization plan.
Provide the inactivated pneumococcal conjugate vaccine and strictly avoid the live MMR vaccine.
This plan maximizes the patient's protection against preventable diseases while avoiding severe iatrogenic infections.

Key Concept

In severely immunocompromised pediatric patients, inactivated vaccines are safe and indicated, whereas live-attenuated vaccines are strictly contraindicated due to the risk of uncontrolled vaccine-strain viral replication.
Question 31Question →

A pediatric clinic is reviewing its protocols for routine well-child visits. Match the following pediatric patients (presenting for routine well-child checks) with the corresponding immunization or developmental screening newly indicated at that specific age according to standard CDC and AAP guidelines.

Click a left item, then click its matching right item

Items

2-month-old infant
12-month-old infant
18-month-old toddler
11-year-old adolescent

Matches

Show answer & explanation

Answer

The 2-month-old matches with the Rotavirus vaccine; the 12-month-old matches with the MMR vaccine; the 18-month-old matches with ASD screening; and the 11-year-old matches with the MenACWY and Tdap booster.
Each age matches its quintessential preventive care milestone: 2 months for starting the primary rotavirus series; 12 months for the initial live-attenuated MMR vaccine; 18 months for standardized ASD screening; and 11 years for the pre-adolescent Tdap booster and meningococcal vaccine.

Step-by-Step Solution

1
Identify the preventive care milestone for the 2-month-old infant.
The 2-month visit is the start of primary vaccine series like rotavirus, DTaP, Hib, PCV, and IPV.
Rotavirus vaccine is initiated early in infancy, with the first dose given at 2 months of age to prevent severe gastroenteritis.
2
Identify the preventive care milestone for the 12-month-old infant.
The 12-month visit marks the introduction of live-attenuated vaccines (MMR and varicella).
Maternal IgG antibodies decrease significantly by 12 months, making live vaccines safe and effective without interference.
3
Identify the preventive care milestone for the 18-month-old toddler.
The 18-month visit includes formal developmental screening specifically targeting autism spectrum disorder (ASD).
AAP guidelines mandate standardized ASD screening (such as the M-CHAT) specifically at 18 and 24 months of age.
4
Identify the preventive care milestone for the 11-year-old adolescent.
The 11-year visit transitions into adolescent care with boosters and new conjugate vaccines.
MenACWY, Tdap, and HPV vaccines are routinely administered at the 11-12 year pre-adolescent well-child visit.

Key Concept

Routine childhood immunization schedules and developmental screening timelines.
Question 32Question →

A family physician is reviewing the timeline for universal screening tests recommended during routine well-child care. Arrange the following universal screening evaluations in chronological order based on the earliest age they are routinely indicated for healthy children.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: Newborn hearing screening (Birth), Standardized autism-specific screening (18 months), Visual acuity testing with optotypes (4 years), and Universal major depressive disorder screening (12 years).
The correct chronological sequence reflects the standard well-child care timeline. Hearing screening is prioritized at birth to prevent language delay. Autism screening is performed at 18 and 24 months when social-communicative deficits become apparent. Vision acuity testing using optotypes requires patient cooperation, which is typically achieved by age 4. Depression screening begins at age 12, corresponding with the onset of adolescence.

Step-by-Step Solution

1
Identify the recommended age for newborn hearing screening.
It is performed at birth.
To ensure early intervention for congenital hearing loss.
2
Identify the recommended age for standardized autism screening.
It is performed at 18 and 24 months.
Signs of autism typically become reliably evident by this age.
3
Identify the recommended age for visual acuity testing using optotypes.
It begins universally at age 4 years.
Children reach the cognitive ability to follow chart instructions.
4
Identify the recommended age for universal depression screening.
It begins at 12 years.
Adolescence is a high-risk period for the onset of major depressive disorder.

Key Concept

The American Academy of Pediatrics recommends a specific timeline for universal well-child screenings, including hearing at birth, autism at 18 and 24 months, visual acuity at 4 years, and depression starting at 12 years.
Estimated Time:1m 0s
Question 33Question →

An adolescent girl, aged 1717 years, comes to the outpatient office for a pre-college physical examination. She plans to move into a university dormitory next month. The patient has a history of perinatally acquired human immunodeficiency virus (HIV) infection. Her adherence to antiretroviral therapy has been poor over the past year. She currently feels well and reports no fever, cough, or weight loss. Her temperature is 37.1∘C37.1^{\circ}\text{C} (98.8∘F98.8^{\circ}\text{F}), blood pressure is 110/70 mmHg110/70 \text{ mmHg}, and pulse is 78/min78/\text{min}. Physical examination is notable for white plaques on the buccal mucosa that can be scraped off with a tongue depressor, as well as generalized non-tender lymphadenopathy. Laboratory studies show a CD4+ T-cell count of 140 cells/mm3140 \text{ cells/mm}^3 and an HIV viral load of 150,000 copies/mL150,000 \text{ copies/mL}. A review of her immunization records shows she received all recommended primary vaccines during infancy but has not received any immunizations since 44 years of age. Which of the following vaccines is contraindicated for this patient during today's visit?

Show answer & explanation

Answer: Measles-mumps-rubella vaccine

Answer

The measles-mumps-rubella (MMR) vaccine is contraindicated due to the patient's severe immunosuppression.
The measles-mumps-rubella vaccine is a live-attenuated viral vaccine. In patients with severe cellular immunodeficiency, such as this patient with HIV and a CD4+ T-cell count less than 200 cells/mm^3 (along with opportunistic oral candidiasis), live vaccines are absolutely contraindicated. Administration can result in severe, disseminated, and potentially fatal infection from the vaccine strains. This patient should only receive inactivated, recombinant, or toxoid vaccines until her CD4+ count improves to an acceptable level with antiretroviral therapy.

Step-by-Step Solution

1
Assess the patient's current immune status based on her clinical presentation and laboratory findings.
The patient has poorly controlled HIV with opportunistic oral candidiasis (thrush) and a CD4+ T-cell count of 140 cells/mm^3, indicating severe immunosuppression.
Determining the degree of immunosuppression is mandatory before administering vaccines, as severe immunodeficiency alters vaccine safety protocols.
2
Determine the safety profile of live-attenuated versus inactivated vaccines for this specific patient.
Live-attenuated vaccines are contraindicated in patients with severe immunosuppression (CD4+ count less than 200 cells/mm^3) due to the risk of uncontrolled replication of the vaccine strain.
A severely compromised cellular immune system cannot properly regulate live vaccine viruses, potentially leading to fatal disseminated infection.
3
Identify which of the listed vaccines is a live-attenuated formulation.
The measles-mumps-rubella vaccine is live-attenuated. The other listed options are inactivated, recombinant, or toxoid vaccines.
Distinguishing between vaccine types allows for the correct identification of the contraindicated immunization.

Key Concept

Live-attenuated vaccines (e.g., measles-mumps-rubella, varicella) are absolutely contraindicated in patients with severe cellular immunosuppression, such as HIV-positive patients with a CD4+ cell count less than 200 cells/mm^3.
Question 34Question →

For each pediatric patient presented below, select the most appropriate routine preventive care intervention or immunization milestone recommended for their specific age according to standard pediatric guidelines.

Click a left item, then click its matching right item

Items

Newborn infant in the nursery prior to hospital discharge
12-month-old toddler presenting for a routine well-child visit
18-month-old toddler presenting for a routine well-child visit
11-year-old adolescent presenting for a routine well-adolescent visit

Matches

Show answer & explanation

Answer

Newborns receive the Hepatitis B vaccine; 12-month-olds receive their first MMR and Varicella vaccines; 18-month-olds undergo routine autism screening; and 11-year-olds receive Tdap, MenACWY, and HPV vaccines.
The Centers for Disease Control and Prevention (CDC) and the American Academy of Pediatrics (AAP) establish a standardized schedule for childhood immunizations and preventive screenings. Birth involves the Hepatitis B vaccine. The 12-month visit is a major milestone for initiating live vaccines (MMR, Varicella). The 18-month visit includes targeted, formal autism screening. The 11-year visit transitions the patient to adolescent care with Tdap, MenACWY, and HPV vaccines.

Step-by-Step Solution

1
Identify the standard preventive care intervention for a newborn infant.
The Hepatitis B vaccine is the hallmark routine immunization given at birth.
This establishes early immunity and prevents perinatal transmission of the virus.
2
Determine the critical interventions scheduled for the 12-month visit.
Live vaccines (MMR and Varicella) are initiated at 12 months.
Circulating maternal antibodies wane by 12 months, allowing the child's immune system to mount an effective response to live vaccines.
3
Recall the specific developmental screening required at 18 months of age.
Autism-specific screening is routinely performed at 18 and 24 months.
Early detection of autism spectrum disorder significantly improves long-term developmental outcomes through early intervention.
4
Identify the adolescent vaccine bundle typically administered at 11 to 12 years of age.
The Tdap booster, MenACWY, and HPV vaccines are administered.
These vaccines provide protection against pertussis, meningococcal meningitis, and HPV-related cancers during adolescence and adulthood.

Key Concept

Routine pediatric preventive care schedule, including indicated immunizations and targeted developmental screening milestones.
Question 35Question →

During a routine primary care visit, the parents of a 5-year-old girl inquire about updating her vaccination status. The patient has a history of acute lymphoblastic leukemia, which was diagnosed six months ago, and she is actively receiving maintenance chemotherapy. Today, she appears well, and her temperature is 36.8°C (98.2°F). Her vaccination records indicate that she is due for her standard 4-to-6-year booster series, consisting of the diphtheria, tetanus, and acellular pertussis (DTaP); inactivated poliovirus (IPV); measles, mumps, and rubella (MMR); and varicella vaccines. What is the most appropriate approach to this patient's immunizations at this time?

Show answer & explanation

Answer: Administer the DTaP and IPV vaccines, but withhold the MMR and varicella vaccines

Answer

Administer the DTaP and IPV vaccines, but withhold the MMR and varicella vaccines.
The correct approach is to administer the inactivated vaccines (DTaP and IPV) while withholding the live-attenuated vaccines (MMR and varicella). Children receiving active chemotherapy are profoundly immunocompromised. In such patients, live-attenuated vaccines pose a severe risk of causing life-threatening, disseminated vaccine-strain infections and are therefore absolutely contraindicated. In contrast, inactivated, subunit, or toxoid vaccines cannot replicate and are safe to administer. Although the immune response to inactivated vaccines may be blunted during chemotherapy, they should still be given on schedule to provide whatever degree of immunity is possible.

Step-by-Step Solution

1
Identify the patient's immune status based on her medical history.
The patient is severely immunocompromised due to active maintenance chemotherapy for acute lymphoblastic leukemia.
Immune status directly determines which classes of vaccines are safe to administer.
2
Categorize the requested vaccines into live-attenuated versus inactivated types.
DTaP and IPV are inactivated vaccines. MMR and varicella are live-attenuated vaccines.
Different vaccine types have distinct safety profiles in immunocompromised hosts.
3
Apply standard immunization guidelines for immunocompromised pediatric patients.
Live-attenuated vaccines must be withheld to prevent vaccine-strain infection, while inactivated vaccines should be administered as scheduled.
This strategy maximizes protection against preventable diseases while avoiding the life-threatening risks associated with live vaccines.

Key Concept

In severely immunocompromised children, such as those on active chemotherapy, live-attenuated vaccines are absolutely contraindicated, while inactivated vaccines should be given as scheduled.
Question 36Question →

A 15-month-old boy is brought to the clinic for a health maintenance visit. At 12 months of age, he was hospitalized for 5 days due to a prolonged fever, bilateral nonexudative conjunctivitis, mucosal changes, and unilateral cervical lymphadenopathy. He was diagnosed with Kawasaki disease and received high-dose aspirin and intravenous immunoglobulin (IVIG). He has fully recovered, and his most recent echocardiogram was normal. His last immunizations were administered at age 6 months. His development is age-appropriate. His vital signs and physical examination today are within normal limits. Which of the following is the most appropriate immunization plan for this patient today?

Show answer & explanation

Answer: Administer DTaP, Hib, and PCV today; defer MMR and varicella vaccines until age 23 months

Answer

The most appropriate plan is to administer the inactivated vaccines (DTaP, Hib, and PCV) today and defer the live-attenuated vaccines (MMR and varicella) until the patient is 23 months of age.
The correct action is to administer the inactivated vaccines today while delaying the live vaccines until the patient reaches 23 months of age. This patient requires catch-up immunizations for those missed at his 12-month visit. Because he was treated with high-dose intravenous immunoglobulin (IVIG) for Kawasaki disease at 12 months of age, his immunization plan must be temporarily modified. IVIG contains a large pool of passively acquired IgG antibodies. These circulating antibodies will bind to and neutralize the weakened viruses present in live-attenuated vaccines (such as the measles, mumps, rubella [MMR] and varicella vaccines), resulting in an inadequate immune response. Therefore, live vaccines must be deferred until the exogenous antibodies have sufficiently degraded. The recommended delay depends on the dose of IVIG; for the high dose (2 g/kg) standardly used in Kawasaki disease, the delay is 11 months. Since he received IVIG at 12 months of age, he can safely receive his live vaccines at 23 months of age. Conversely, circulating antibodies do not significantly impair the immune response to inactivated vaccines or toxoids. Therefore, inactivated vaccines (such as DTaP, Hib, and PCV) should be administered today without delay to protect the child from these serious infections.

Step-by-Step Solution

1
Identify the patient's current immunization status and age.
The patient is 15 months old and missed his 12-month immunizations, meaning he requires both inactivated (DTaP, Hib, PCV) and live-attenuated (MMR, varicella) vaccines.
Determining which vaccines are due is the first step in formulating a catch-up vaccination plan.
2
Evaluate the impact of his recent medical history on vaccine efficacy.
He received high-dose IVIG for Kawasaki disease at 12 months of age.
Blood products containing concentrated IgG antibodies can interfere with the body's immune response to certain vaccines.
3
Apply the clinical guidelines for vaccine administration following IVIG therapy.
Inactivated vaccines can be given immediately, but live-attenuated vaccines must be delayed for 11 months following high-dose IVIG (2 g/kg).
Passive IgG from IVIG neutralizes live vaccine viruses but does not significantly affect the immune response to inactivated vaccines or toxoids.
4
Calculate the appropriate timing for the delayed vaccines.
MMR and varicella should be given 11 months after the IVIG was administered at 12 months of age, which corresponds to 23 months of age.
This ensures adequate time for passive antibodies to degrade, allowing for an effective, lasting immune response to the live vaccines.

Key Concept

High-dose intravenous immunoglobulin (IVIG) administration necessitates an 11-month delay for live-attenuated vaccines to prevent passive antibodies from neutralizing the vaccine virus. Inactivated vaccines can be administered on their normal schedule without delay.
Question 37Question →

A clinical director at a pediatric outpatient center is developing an electronic medical record algorithm for routine well-child preventive care. The system must prompt clinicians for age-appropriate immunizations for a healthy, full-term child born to a Hepatitis B surface antigen-negative mother. Arrange the administration of the following specific vaccine doses in the correct chronological order of their routine initial administration, from the earliest age to the oldest age.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence from earliest to latest is: 1) First dose of Hepatitis B vaccine (birth), 2) First dose of Rotavirus vaccine (2 months), 3) First dose of MMR vaccine (12-15 months), 4) Fifth dose of DTaP vaccine (4-6 years), and 5) First dose of HPV vaccine (11-12 years).
The routine United States immunization schedule strictly dictates age boundaries to optimize immunogenicity and provide protection when children are most vulnerable. The schedule flows chronologically from birth (Hepatitis B), to the 2-month primary series (Rotavirus), to the 1-year mark for live vaccines (MMR), followed by school-entry boosters (DTaP dose 5), and concluding with adolescent vaccines (HPV).

Step-by-Step Solution

1
Identify the vaccine administered immediately after delivery.
Hepatitis B first dose is given at birth.
It is the only routine childhood immunization indicated within the first 24 hours of life to prevent vertical and early horizontal transmission.
2
Identify the vaccines initiated during early infancy well-child visits.
Rotavirus first dose is given at 2 months.
The primary infant series (which includes Rotavirus, DTaP, Hib, PCV, and IPV) commences at 2 months of age.
3
Identify the timeline for live-attenuated vaccines.
MMR first dose is given at 12-15 months.
Maternal IgG antibodies transferred across the placenta degrade by age 1; giving live vaccines before this time can neutralize the vaccine virus and prevent a protective immune response.
4
Identify the booster vaccines required for school entry.
DTaP fifth dose is given at 4-6 years.
Immunity wanes after the infant and toddler series, necessitating a booster prior to kindergarten.
5
Identify the vaccines indicated for preadolescent preventive care.
HPV first dose is given at 11-12 years.
Administering the vaccine at this age provides the strongest immunogenic response and protection prior to the onset of sexual activity.

Key Concept

Routine childhood immunization schedule timing and age-appropriate vaccine administration.
Question 38Question →

A community health clinic is preparing an educational brochure for first-time parents regarding what to expect during their infant's first year of life. As part of the anticipatory guidance on normal neurodevelopment, the nursing staff is outlining key social, language, and cognitive milestones. Arrange the following developmental milestones in the typical chronological order of their expected emergence, from earliest to latest.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: social smile (2 months), babbling with consonants (6 months), peek-a-boo and stranger anxiety (9 months), and specific use of mama/dada (12 months).
Developmental screening and anticipatory guidance are core components of routine pediatric well-child visits. The correct chronological progression of these milestones starts with a reciprocal social smile at 2 months. By 6 months, infants begin consonant babbling and turn toward their own name. At 9 months, they begin to understand object permanence, enabling them to play peek-a-boo and exhibit stranger anxiety. By 12 months, their language progresses to using 'mama' and 'dada' specifically to refer to their parents, and they may have 1 or 2 additional words.

Step-by-Step Solution

1
Identify the emergence of the social smile.
Assigned as the earliest milestone.
Infants typically begin to smile reciprocally in response to caregiver interaction around 2 months of age.
2
Identify the emergence of consonant babbling and recognizing one's name.
Assigned as the second milestone.
By 6 months of age, infants typically begin consonant babbling (e.g., 'ba-ba') and will turn their head toward their own name.
3
Identify the emergence of stranger anxiety and interactive play.
Assigned as the third milestone.
At 9 months of age, object permanence solidifies, leading to stranger anxiety and the ability to play interactive games like peek-a-boo.
4
Identify the specific use of parental names.
Assigned as the final milestone.
At 12 months of age, infants use 'mama' and 'dada' specifically to refer to their parents, distinguishing them from other adults.

Key Concept

Recognizing normal pediatric developmental milestones in the first year of life is an essential component of developmental screening during routine preventive care visits.
Estimated Time:45s
Question 39Question →

Parents bring their 8-week-old daughter to the clinic for a well-child examination. The infant was born at full term without any peripartum complications. However, her newborn screening panel returned positive for severe combined immunodeficiency (SCID), which was subsequently confirmed by flow cytometry. She is currently receiving prophylactic antimicrobials and is scheduled for a hematopoietic stem cell transplant in the near future. Vital signs today are within normal limits, and physical examination is unremarkable. The pediatrician and the parents review the infant's immunization schedule. Which of the following vaccines must be withheld from this patient's regimen today?

Show answer & explanation

Answer: Rotavirus

Answer

The rotavirus vaccine must be withheld.
The correct answer is the rotavirus vaccine. Patients with severe combined immunodeficiency (SCID) lack functional T cells and B cells, placing them at extreme risk for severe, life-threatening infections. Because live-attenuated vaccines contain active pathogens that can replicate and cause clinical disease in an immunocompromised host, they are absolutely contraindicated. The rotavirus vaccine, administered orally, is the only live-attenuated vaccine on the standard 2-month immunization schedule.

Step-by-Step Solution

1
Identify the patient's underlying medical condition and its immunological impact.
The patient has severe combined immunodeficiency (SCID), which involves profound defects in cellular (T-cell) and humoral (B-cell) immunity.
Understanding the degree of immunodeficiency is required to determine vaccine safety.
2
Determine the general rule for immunizations in patients with severe cellular immunodeficiency.
Live-attenuated vaccines are absolutely contraindicated because the weakened vaccine strains can replicate uncontrollably and cause severe, disseminated infection.
This is a fundamental principle of preventive care in immunocompromised hosts.
3
Classify the standard 2-month vaccines (DTaP, Hib, IPV, PCV, HepB, Rotavirus) as live or inactivated.
Rotavirus is the only live-attenuated vaccine on the routine 2-month schedule. All others are inactivated toxoid, recombinant, or conjugate vaccines.
Identifying the live vaccine allows for the correct selection of the contraindicated immunization.

Key Concept

Live-attenuated vaccines are absolutely contraindicated in patients with severe combined immunodeficiency (SCID) due to the risk of uncontrolled vaccine-strain infection.
Estimated Time:1m 0s
Question 40Question →

A 12-month-old girl is brought to the clinic for a routine well-child visit. She was diagnosed with perinatal human immunodeficiency virus (HIV) infection. Over the past 6 months, she has been treated for an episode of *Pneumocystis jirovecii* pneumonia and recurrent oral candidiasis. Her current medications include a combination antiretroviral therapy regimen and trimethoprim-sulfamethoxazole. Her mother expresses concern because the infant is pulling to a stand and cruising along furniture but is not yet walking independently without support. The infant babbles and consistently says "mama" and "dada." Vital signs are within normal limits for age. Physical examination is unremarkable. Laboratory studies obtained 3 days ago show a CD4 T-lymphocyte percentage of 12%. The patient has received all previously scheduled age-appropriate immunizations. Which of the following is the most appropriate next step in management regarding this patient's preventive care today?

Show answer & explanation

Answer: Administer scheduled inactivated vaccines and withhold live-attenuated vaccines

Answer

Administer scheduled inactivated vaccines and withhold live-attenuated vaccines
The correct course of action is to administer the scheduled inactivated vaccines and withhold the live-attenuated vaccines. At 12 months of age, children routinely receive both inactivated vaccines (such as the pneumococcal conjugate and hepatitis A vaccines) and live-attenuated vaccines (such as the measles-mumps-rubella [MMR] and varicella vaccines). However, this patient has HIV with a CD4 T-lymphocyte percentage of 12%. According to immunization guidelines, a CD4 percentage less than 15% represents severe immunosuppression. In this state, live-attenuated vaccines are absolutely contraindicated because they can cause widespread, life-threatening vaccine-strain infections. Inactivated vaccines, on the other hand, cannot replicate and are completely safe. They should be administered on schedule to provide crucial protection against other infections.

Step-by-Step Solution

1
Assess the patient's age and routinely indicated vaccines.
At 12 months of age, children are typically scheduled to receive a mix of inactivated vaccines (e.g., PCV, HepA, Hib) and live-attenuated vaccines (MMR, Varicella).
Establishing the baseline well-child recommendations helps determine what interventions are currently due.
2
Evaluate the patient's immune status and comorbidities.
The patient has HIV with a CD4 T-lymphocyte percentage of 12% and a history of opportunistic infections.
Vaccination safety, particularly for live vaccines, relies heavily on the patient's level of immunocompetence.
3
Apply immunization guidelines for HIV-infected children.
A CD4 percentage of less than 15% in a child of any age indicates severe immunosuppression. Live vaccines must be withheld. Inactivated vaccines should be given as scheduled.
Live-attenuated vaccines pose a severe risk of disseminated infection in severely immunocompromised hosts. Inactivated vaccines pose no infectious risk.
4
Evaluate the mother's developmental concerns.
Pulling to stand, cruising, and saying 'mama'/'dada' are normal gross motor and language milestones for a 12-month-old.
To ensure there are no other contraindications or urgent conditions that take precedence over routine preventive care.

Key Concept

In pediatric patients with HIV and severe immunosuppression (CD4 percentage < 15%), live-attenuated vaccines (e.g., MMR, Varicella) are contraindicated, but inactivated vaccines should be administered according to the routine schedule.
PreviousPage 2 / 6Next
Preventive Care and Immunizations Practice Questions — USMLE Step 2 CK — Page 2 | Examkin